Dexlansoprazole (DEXILANT): Difference between revisions
From SEHK Wiki
No edit summary Tag: Reverted |
No edit summary Tag: Reverted |
||
| Line 33: | Line 33: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach | Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach | ||
==Route of Administration== | |||
Oral | |||
Revision as of 02:22, 6 January 2025
Drug class: Proton Pump Inhibitors (PPI)
Dexlansoprazole (中文: 右蘭索拉唑)
Drug Class
Proton Pump Inhibitors (PPI)
Common Strengths of Dexlansoprazole capsule
Dexlansoprazole capsule are available in the following strengths:
- 30 mg delayed-release capsules
- 60mg delayed-release capsules
Drug Trade Names of Dexlansoprazole capsule
Dexilant
Drug Usage
Dexlansoprazole is used for:
- Healing of erosive esophagitis (EE)
- Maintenance of healed erosive esophagitis (EE)
- Treatment of gastroesophageal reflux disease (GERD)
Mechanism of Action
Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach
Route of Administration
Oral
